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Abstract
We demonstrated recently that frontal cortical expression of the Neuregulin (NRG) receptor ErbB4 is restricted to
interneurons in rodents, macaques, and humans. However, little is known about protein expression patterns in other areas
of the brain. In situ hybridization studies have shown high ErbB4 mRNA levels in various subcortical areas, suggesting that
ErbB4 is also expressed in cell types other than cortical interneurons. Here, using highly-specific monoclonal antibodies, we
provide the first extensive report of ErbB4 protein expression throughout the cerebrum of primates. We show that ErbB4
immunoreactivity is high in association cortices, intermediate in sensory cortices, and relatively low in motor cortices. The
overall immunoreactivity in the hippocampal formation is intermediate, but is high in a subset of interneurons. We detected
the highest overall immunoreactivity in distinct locations of the ventral hypothalamus, medial habenula, intercalated nuclei
of the amygdala and structures of the ventral forebrain, such as the islands of Calleja, olfactory tubercle and ventral
pallidum, and medium expression in the reticular thalamic nucleus. While this pattern is generally consistent with ErbB4
mRNA expression data, further investigations are needed to identify the exact cellular and subcellular sources of mRNA and
protein expression in these areas. In contrast to in situ hybridization in rodents, we detected only low levels of ErbB4-
immunoreactivity in mesencephalic dopaminergic nuclei but a diffuse pattern of immunofluorescence that was medium in
the dorsal striatum and high in the ventral forebrain, suggesting that most ErbB4 protein in dopaminergic neurons could be
transported to axons. We conclude that the NRG-ErbB4 signaling pathway can potentially influence many functional
systems throughout the brain of primates, and suggest that major sites of action are areas of the ‘‘corticolimbic’’ network.
This interpretation is functionally consistent with the genetic association of NRG1 and ERBB4 with schizophrenia.
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Introduction
Single nucleotide polymorphisms (SNPs) in the genes encoding
Neuregulin-1 (NRG1) and its receptor ErbB4 are associated with
increased risk for and endophenotypes of schizophrenia [1–3];
NRG1 is also associated with bipolar disorder [4,5]. A recent
genetic association study reported epistasis between SNPs in
NRG1, ERBB4 and AKT1, a signaling protein that physically
interacts with the cytoplasmic tail of an ErbB4 splice variant
known as cyt-1 [6].
The appreciation that ErbB4, initially called Tyro-2 [7], in
rodents is expressed in neocortical and hippocampal interneurons
[8,9], and that its expression is restricted to specific subsets of
interneurons but is absent from pyramidal cells [10,11], has been
essential for understanding many of the functions of this intricate
signaling pathway during neural development and in the adult
brain. ErbB4 expression in the primate frontal cortex was found to
occur in most interneurons that express either parvalbumin,
calretinin or cholecystokinin, but only in the minority of calbindin-
positive interneurons [12]. Studies in the frontal cortex and
hippocampus of rodents have shown that acute activation of
ErbB4 by bath application of NRG1 modulates GABAergic
transmission [13–15] and synaptic plasticity at glutamatergic
synapses [16–19]. Moreover, in the hippocampus it has been
shown that NRG1 regulates synaptic plasticity at principal
neurons by promoting dopamine release, activation of dopamine
D4 receptors and subsequent internalization of GluA1-containing
AMPA receptors [20]. Furthermore, NRG1-ErbB4 signaling
acutely augments hippocampal gamma oscillations [21] and
promotes the generation and migration of cortical interneurons
[22,23] as well as the formation and maintenance of interneuron
synapses [15,24]. Taken together, the finding of recruitment of
GABAergic, glutamatergic and dopaminergic signaling by the
NRG1-ErbB4 pathway provides a biologically plausible mecha-
nism that is consistent with its genetic association (see above) and
consolidates many hypotheses on the involvement of different
neurotransmitter systems in the etiology of schizophrenia (re-
viewed in [3]).
However, in order to better understand the possible functional
role of this signaling pathway in human disorders, it is imperative
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Data obtained by in situ hybridization indicate ErbB4 transcripts
are expressed in many small cells scattered throughout the cerebral
cortex of rhesus monkeys and in additional distinct subcortical
structures (Allen Brain Atlas [25]). With regard to protein
expression, we have recently shown [12] that previous reports
on widespread expression of ErbB4 on both interneurons and
pyramidal neurons in the cerebral cortex of monkeys and humans
[26–28] should be taken with caution, because these studies used
commercial antibodies of limited specificity. In contrast, using
monoclonal antibodies rigorously tested for specificity in tissues of
ErbB4 knockout mice, we found that frontal cortical expression of
the receptor in monkeys and humans is restricted to the
somatodendritic compartment of GABAergic interneurons and is
absent from pyramidal cells [12]. These studies showed that the
cellular and subcellular distribution of ErbB4 in the frontal cortex
is similar across rodents and primates. However, all current
expression data are restricted to small brain areas and there is yet
no data available on ErbB4 protein expression throughout the
entire brain.
Our present study was thus designed to provide a systematic
overview on ErbB4 expression throughout major structures of the
cerebrum of rhesus monkeys. ErbB4 was detected using highly
specific mouse and rabbit monoclonal antibodies that are directed
against extracellular and intracellular epitopes, respectively, and
microscopic detection and imaging of immunofluorescence were
executed in a way that facilitates the comparison of expression
levels across different brain sections and brain areas. Our results
are presented with a focus on functional systems and indicate that
ErbB4 protein expression is considerably higher in ‘‘corticolimbic’’
areas compared to regions that are primarily implicated in sensory
and motor functions. In general, our current findings in monkeys,
together with previously published data on rodents, suggest that
the regional expression pattern of ErbB4 is largely conserved
throughout the brains of rodents and primates. These results
support the view that studies of the NRG/ErbB4 pathway in
rodents can significantly contribute to understanding the etiology
and the biological processes altered in psychiatric disorders.
Materials and Methods
Ethics Statement
All procedures carried out were in strict adherence to the ILAR
‘‘Guide for the Care and Use of Laboratory Animals’’ and
approved by the NIMH Animal Care and Use Committee. The
monkey facility is an AAALAC approved facility. Rhesus monkeys
were maintained in pairs, under 12-hour dark and light cycles, and
were given free access to food and water ad libitum. Three male
C57Bl/6J mice (ages p70–p90) were obtained from Jackson
Laboratories (Bar Harbour, ME). The animals of this study, rhesus
monkeys as well as mice, were not subject to experimental
treatment of any kind. Their health was monitored by the
attending veterinarian consistent with the recommendations of the
Weatherall Report. The animals were euthanized following deep
anesthesia, and all efforts were made to minimize suffering.
Immunohistology
Immunohistological experiments were performed on sections
from two male adult rhesus monkeys (Macaca mulatta; ages 7 years
and 12.5 years) that were kindly provided by Dr. Richard
Saunders of the National Institute of Mental Health. Monkeys
were deeply anesthetized with sodium pentobarbital and were
subsequently euthanized with Euthanasia-iii (Med-Pharmex,
Pomona, CA), and then transcardially perfused with 1 L saline
followed by 3 L of 4% paraformaldehyde. Heparin (1 ml) was
administered i.v. prior to the perfusion. Following perfusion, the
extracted brain was cryoprotected in 2 L of 10% glycerol and 2%
DMSO in 0.1 M phosphate buffer for 24 h, followed by 2 L of
20% glycerol and 2% DMSO in 0.1 M phosphate buffer for 5
days at 4uC on an orbital shaker. Once the cryoprotection process
was complete, the brain was blocked and then frozen using
isopentane (4-methyl butane) at 280uC, where it was stored until
sectioning. The left hemisphere was sectioned on a sliding
microtome using a freezing stage at a thickness of 40 mm. All
sections were individually collected in 48-well tissue culture plates,
generating ten systematic random sets of ,130 sections each (total
,1,300 sections per animal). The sections were stored in
cryoprotectant solution (20% glycerol and 30% ethylene glycol
in 50 mM phosphate buffer) at 220uC. The perfusion and tissue
processing of mice have recently been described in detail elsewhere
[12], and the immunofluorescent labeling procedure was identical
for monkey and mouse tissues.
Sections were processed for double-immunofluorescence in
0.1 M TBS pH 7.5 with 0.2% Triton-X100 as follows (standard
conditions): 2610 min washes; 1 h in 2% H2O2 in order to
inactivate endogenous peroxidase activity; 3610 min washes;
blocking of endogenous streptavidin-biotin binding sites according
to the manufacturer’s instructions (Vector Laboratories, Burlin-
game, CA); 3610 min washes; 1 h blocking in 10% normal
donkey serum; incubation in primary antibodies for 40 h at 4uCi n
blocking solution; 3610 min washes; biotinylated and/or fluor-
ophor-labeled secondary antibodies for 1 h in blocking solution;
3610 min washes; streptavidin-peroxidase (Sigma Aldrich, St.
Louis, MO) for 1 h; 3610 min washes. Sections were then stained
with Tyramide-Alexa 488 (Invitrogen, Carlsbad, CA) according to
the manufacturer’s instructions, washed 3610 min, mounted in
Mowiol-DABCO, and stored at 4uC. All steps of the protocol were
executed on an orbital shaker at 50 rpm and were done at room
temperature unless stated otherwise. Minimum solution volumes
per brain section were as follows: washes in 5 ml buffer (mice:
1 ml), incubation in antibodies, avidin or tyramide in 2 ml (mice:
0.4 ml); the smaller monkey sections of the prefrontal cortex and
the nucleus accumbens were incubated together, using the same
volume that was used for the larger sections through the amygdala
or the hippocampus.
In order to reveal intracellular ErbB4 immunoreactivity, heat-
induced antigen retrieval with buffer U at 121uC was used
according to the manufacturer’s instructions (2100 Retriever,
PickCell Laboratories, Amsterdam, Netherlands). Following anti-
gen retrieval, the standard protocol was followed as described
above. As controls, sections without primary and/or secondary
antibodies and/or streptavidin exhibited only low-intensity general
background fluorescence and autofluorescent grains; an example
obtained from the anterior cingulate cortex is provided. Control
experiments were performed in parallel with other experiments
using the same solutions on monkey and mouse sections with and
without antigen retrieval. Primary antibodies are shown in Table 1.
Secondary antibodies: donkey anti-rabbit Cy3 (1:1000), donkey
anti-mouse Cy3 (1:1000), donkey anti-goat Cy3 (1:1000), donkey
anti-rat Cy 3(1:500), donkey anti-mouse Cy2 (1:300), biotinylated
donkey anti-rabbit (1:1000) and biotinylated donkey anti-mouse
(1:500; all from Jackson ImmunoResearch, West Grove, PA). All
secondary antibodies were highly affinity-purified (ML quality) to
minimize cross-reactivity.
The rabbit monoclonal anti-ErbB4 antibody directed against
the intracellular domain (mAb-10) has undergone stringent tests
for specificity in a variety of applications that include Western
blotting, immunoprecipitation, and immunolabeling of cultured
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the mouse monoclonal mAb-77 directed against the natively
folded extracellular domain of human ErbB4 was demonstrated
previously [11,29]. Moreover, specificity of mAb-10 and mAb-77
was demonstrated on monkey and human brain tissue [12]. Major
neuronal cell classes were identified using selective and specific
antibodies against neurogranin, neurofilament H and GAD67.
Neurogranin is a selectively marker for the majority of
glutamatergic principal neurons in the telencephalon of both
rodents and primates [30,31]. Neurofilament H was detected with
a widely used and well characterized monoclonal antibody; the
protein is expressed in principal neurons projecting to distant
areas, and the amount of immunoreactivity positively correlates
with the size of the cells [32]. GAD67 is selectively expressed by
GABAergic neurons and is a marker for interneurons in the
cerebral cortex; however, immunoreactivity may be absent from
certain subpopulations of interneurons [33]. Selectivity and
specificity of the GAD67 antibody was tested by co-immunoflu-
orescence with several other markers of interneurons on rodent
and monkey brain sections, including GABA, and a GAD67
antibody that is directed against a different epitope.
Microscopy and imaging
Immunofluorescence was analyzed using a confocal microscope
(Zeiss 510 Meta) at 10x, 20x, 40x Oil and 63x Oil magnification.
Low magnification images were obtained in a single z-plane,
whereas higher magnification images (40x and 63x) represent
maximum projections of image stacks of 4–8 z-planes. The
separation of image planes along the z-axis was set using the
‘‘Optimal Interval’’ function within the Zeiss LSM 5 acquisition
software that automatically considers the objective in use and
additional microscope settings; the usual separation of z-planes
was in the range of 0.3–0.5 mm with a 20% overlap of subsequent
z-planes. Large image arrays of entire sections were obtained with
a fully motorized Zeiss AxioImager Z1 epifluorescence microscope
at 10x magnification in a single z-plane, and automatically
collected and assembled from up to 1100 single images with Zeiss
AxioVision 4.8 software. The presented images are representative
for the staining patterns, and were adjusted for overall brightness
and contrast using Adobe Photoshop CS4.
The entire procedure for immunofluorescent labeling, imaging,
image assembly and post-processing was standardized to allow the
comparison of expression levels across different sections and
different areas throughout the brain. The imaging sensitivity in
Figures 1, 2, 3 was chosen to display entire sections; therefore,
some brain areas such as the mesencephalic nuclei (Figure 3) show
little signal and only in areas of highest epifluorescence the signal
was saturated. Please note that the imaging sensitivity was
considerably increased in later figures to present ErbB4 immuno-
reactivity that is still clearly above background levels in the same
mesencephalic nuclei at higher magnification using confocal
microscopy. Again, in order to allow qualitative comparisons with
respect to signal intensity between brain areas within the
corticolimbic and the sensory-motor systems, imaging parameters
were held constant during imaging of cortical profiles and the
basal ganglia, e.g. in Figure 4 (panels A, C, D, F).
Please note that imaging in the dorsal part of the section
presented in Figure 2A was not possible in the TH-channel (red)
because of a large staining artifact; the green channel was not
affected by this event. In order to provide an overview image with
realistic color distribution, TH staining in the dorsal cortex was
replaced with generic pixel values in the red channel that are
representative for the pixel intensity as determined from parallel
sections.
Qualitative analysis of immunofluorescence intensity
Cortical and subcortical areas were identified by analyzing their
shape and their location with respect to neighboring structures on
series of sections immunolabeled for either tyrosine hydroxylase
(TH), GAD67, parvalbumin (PV), neurogranin, or neurofilament
H (SMI-32), and in a few cases Nissl-stained sections, and
comparison with a rhesus monkey brain atlas [34]. A list of
operational definitions of major areas is provided in Table S1. In
order to facilitate the identification of cortical areas and
subcortical structures, brain sections were selected in order to
closely reflect the anterior-posterior levels presented in the brain
atlas. A minimum of two sections per area, and in most cases three
to five sections per area, were analyzed in both monkeys using
identical experimental protocols. In addition both ErbB4 mono-
clonal antibodies were used on sections from both monkeys. The
Table 1. List of primary antibodies.
Species Antigen Clone Source Item # Dilution
mouse parvalbumin PARV-19 Sigma-Aldrich, St. Louis, MO P3088 1:5000
rabbit parvalbumin poly Swant, Bellinzona, CH PV-25 1:1500
rabbit nNOS poly Invitrogen, Carlsbad, CA 61–7000 1:4000
rabbit calretinin poly LabVision, Fremont, CA RB-9002-P0 1: 2000
mouse ErbB4, mAb-77 H4.77.16 LabVision MS-270 3 mg/ml
rabbit ErbB4, mAb-10 mAb-10 Vullhorst et al., 2009 mAb-10 3 mg/ml
rabbit neurogranin poly Millipore, Temecula, CA AB5620 1:2000
mouse GAD67 1G10.2 Millipore MAB5406 1:5000
rabbit GAD67 poly Millipore AB9706 1:2000
rat somatostatin YC7 Millipore MAB354 1:200
goat ChAT poly Millipore AB144P 1:500
rabbit tyrosine hydroxylase poly Novus, Littleton, CO NB300-109 1:2000
mouse neurofilament H SMI-32 Abcam, Cambridge, UK ab75475 1:2000
Abbreviations: choline acetyltransferase (ChAT), glutamic acid decarboxylase 67 kD (GAD67), neuronal nitric oxide synthase (nNOS).
doi:10.1371/journal.pone.0027337.t001
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parvalbumin and neurofilament H staining; however, no attempt
was made to locate their exact boundaries or to subdivide single
layers, as in the case of the highly-structured layer IV of the
primary visual cortex (V1).
In the description of signal intensities in different brain areas
and cortical layers, arbitrarily set thresholds were used to
distinguish high, medium, and low levels of immunoreactivity;
occasionally we classified intensity in some regions as low to medium
or medium to high when we found greater than usual variability
between sections. The variability of inter-area differences on single
sections and between sections that were labeled in a single
experiment was smaller than the variability between sections that
were immunolabeled in different experiments. Signal intensities
Figure 1. Overview on ErbB4 expression in nucleus accumbens, dorsal striatum and surrounding cortex. (A) Single epifluorescence
images (868) of a frontal lobe section double-labeled for ErbB4 (mAb-77, green channel) and TH (red channel) were taken at 10x magnification and
automatically assembled. The drawing indicates the approximate anteroposterior position of the section (red line). Immunofluorescence of TH
highlights the Cd, Pu, NAC and OTu. ErbB4 expression is evident in all cortical areas; however, immunoreactivity is stronger in dorsal and lateral cortex
compared to medial and ventral areas. ErbB4 is expressed at medium levels in the striatum with patches of higher immunofluorescence being
evident in the NAC and OTu. The location of areas of interest shown at higher magnification in panels B and C is indicated by rectangles. (B) ErbB4
expression is restricted to small multipolar neurons (arrows) in deep layers of cortical area 6, whereas large, fuzzy areas of high intensity (C) occura t
the border of OTu and NAC in the ventral forebrain. Scale bar=2 mm (A), 220 mm (B, C). Abbreviations: Supplementary motor area and premotor
cortex (6), anterior cingulate cortex (24), subgenual prefrontal cortex (25), caudate (Cd), claustrum (Cl), cortical layers (L5, L6), nucleus accumbens
(NAC), olfactory tubercle (OTu), putamen (Pu).
doi:10.1371/journal.pone.0027337.g001
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measurement of mean pixel intensity and standard deviation
(SD) throughout the entire area under investigation (see Figure S1)
whenever its boundaries were detectable using simple morpho-
logical criteria (e.g. cortical sulci in the case of the insular cortex)
or characteristic immunoreactivity (e.g. tyrosine hydroxylase for
the dorsal striatum or parvalbumin for the reticular thalamus).
However, since we did not attempt to determine the exact
boundaries of all cortical areas of interest, in some cases we instead
evaluated fluorescence intensity in 500 mm-wide radial profiles
through all cortical layers near the presumed center of the area, in
order to stay within its boundaries. Similarly, if the exact
boundaries of subcortical structures could not be clearly
determined, regions of interest were drawn within the unambig-
uously identified core structures. Qualitative differences in signal
intensities between cortical layers were determined by smoothing
the image profile of the cortical area with a Gaussian filter (Passes:
1; Strength: 30) and analysis of a histogram along a radial profile
(see Figure S2). Please note that all images presented in the figures
were obtained from the same rhesus monkey because of better
tissue quality, i.e. consistent absence of both cryoartifacts and
sectioning artifacts. However, area-specific mean intensity values
were calculated using data from both monkeys, and the sections
presented in Figures 1, 2, 3 were selected in order to reflect the
entirety of data on mean intensities and inter-area differences
closely.
We noticed that high levels of autofluorescence (probably caused
by intracellular accumulations of lipofuscin) give the false
impression of immunoreactive signal in some areas, e.g. in the
lateral geniculate nucleus (Figure 3A); where appropriate, we
commented on this signal in the figure legends. Technically,
lipofuscin-derived autofluorescence can be distinguished from
immunofluorescence by imaging in additional channels (e.g.
405 nm or 635 nm) that should be devoid of immunofluorescent
signal from either Alexa 488 / Cy2 or Cy3 fluorophores, which
were exclusively used in our experiments. We present examples of
this procedure in the external globus pallidus (Figure 2D) and in the
lateral geniculate nucleus (Figure 3D) where the far red channel at
635 nm was used to identify strongly autofluorescent somata.
Results
ErbB4 immunoreactivity is generally high in the cortex
but differs between subcortical structures
We started our analysis of ErbB4 protein expression in the
primate brain by collecting and assembling low-magnification
epifluorescence images of entire coronal sections in order to get an
overview of the general pattern of ErbB4 expression throughout
major areas of the monkey cerebrum. The sections were co-
immunolabeled for tyrosine hydroxylase (TH) to facilitate identifi-
cation of the nucleus accumbens, dorsal striatum, and mesence-
phalic nuclei. In order to allow qualitative comparisons between
different sections and brain areas, Figures 1, 2, 3 show sections that
were immunolabeled together using the mouse mAb-77 ErbB4
antibody, and data collected using identical microscope settings and
standardized post-acquisition image processing (see Methods).
Figure 1A presents ErbB4 expression in a section through the
frontal lobe, including the rostral striatum and the nucleus
accumbens. ErbB4 immunoreactivity was evident in all cortical
areas, with higher overall levels in dorsal and lateral areas
compared to ventral cortex. Images presented at original
resolution show that cortical immunolabeling occurred in small
somata that were scattered throughout the cortex, and in the
surrounding neuropil (Figure 1B), consistent with our recent
description of selective ErbB4 expression in a subset of
interneurons in the prefrontal cortex of rhesus monkeys [12].
Immunofluorescence was largely absent from white matter at low
magnification. We detected medium to high levels of ErbB4 in the
TH-immunoreactive basal ganglia, including caudate nucleus,
putamen, nucleus accumbens, and low to medium levels in the
claustrum where TH-innervation was largely absent. In addition,
patches of high protein expression occurred frequently in the
ventral forebrain (Figure 1C); similar expression patterns in the
ventral forebrain have been reported previously for ErbB4 mRNA
in rodents [35,36]. However, in contrast to the cortex, labeling was
mostly diffuse in the striatum and ventral forebrain, indicative of
expression on neuropil rather than neuronal somata. Thus,
additional studies are needed in order to resolve to what extent
ErbB4 transcripts and protein may be targeted to somata versus
neuropil in these rostral subcortical areas.
Figure 2A shows ErbB4 expression in a section through the
rostral thalamus, hypothalamus and amygdala. Again, the striatum
can be identified by TH immunofluorescence. The gradient of
higher expression levels in dorsal cortex compared to ventral
cortex, described in Figure 1, was maintained at this rostrocaudal
level, and ErbB4 immunofluorescence was largely absent from
cortical white matter and fiber bundles such as the optic tract. We
detected medium ErbB4 levels in both the external and internal
subdivisions of the globus pallidus in addition to medium to high
expression in the striatum, arguing for a potentially important
functional role of ErbB4 in subcortical motor signal processing.
Medium immunoreactivity was also evident in the reticular
thalamic nucleus (RTN). This finding is consistent with mRNA
expression in the RTN of rodents as has been shown repeatedly by
in situ hybridization [7,35,37,38]. Images at original resolution
reveal ErbB4 expression in a high number of small somata in
cortical layers 2–3 but not in layer 1 (Figure 2B), and in the
subcortical claustrum (Figure 2C). Expression in the putamen was
Figure 2. Overview on ErbB4 expression in dorsal striatum, pallidum, thalamus, hypothalamus, amygdala, and surrounding cortex.
(A) Single epifluorescence images (1064) were taken at 10x magnification and automatically assembled; antibody staining and channels as in Figure 1.
The drawing indicates the approximate anteroposterior position of the section (red line). Immunofluorescence of TH highlights Cd, Pu, and Inf. ErbB4
expression is evident in all cortical areas; however, immunoreactivity is stronger in dorsal compared to ventral areas. ErbB4 is expressed at high levels
in patches in the amygdala that correspond to the intercalated nuclei (arrows in A). High concentration of ErbB4 is also evident in the ventral HTh and
Inf. Original resolution is shown in apical layers of cortical areas S2 and InC (B) and in the basal ganglia at the border of Pu and Cl (C); ErbB4 expression
(green channel) is evident in small multipolar neurons in these areas (arrows). In addition, the Pu shows a medium level of fuzzy immunofluorescence
that is absent from the Cl. The position of (B, C) is indicated by rectangles in (A). (D) Fluorescent imaging control in GPe (location is indicated by the
yellow box in A) distinguishes autofluorescence (indicated by arrowheads) from specific immunoreactivity in the red and green channels (arrows);
note signal on somata in the far red channel (633 nm) that reveals unspecific fluorescence (see Methods for more information). Scale bar=2 mm (A),
220 mm (B, C), 160 mm (D). Abbreviations: third ventricle (3
rdv), anterior/posterior cingulate cortex (24/23), anterior thalamic nucleus (ATN), basal
amygdala (BA), caudate (Cd), claustrum (Cl), cortical layers (L1, L2/3), internal entorhinal cortex (ECi), globus pallidus externa/interna (GPe/i),
hypothalamus (HTh), intercalated amygdala (IcA), infundibulum (Inf), insular cortex (InC), lateral amygdala (LA), optic tract (ot), periamygdaloid cortex
3 (PAC3), putamen (Pu), reticular thalamic nucleus (RTN), somatosensory cortex (S2).
doi:10.1371/journal.pone.0027337.g002
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neuropil shows medium fluorescence intensity (Figure 2C). This
pattern suggests that intraareal ErbB4 expression in the striatum is
restricted to interneurons and is absent from principal cells, i.e.
medium spiny neurons, similar to the cerebral cortex. Both the
intercalated nuclei of the amygdala and the ventral hypothalamus
displayed high ErbB4-immunofluorescence, consistent with previ-
ous reports in rodents [7,35,39]. Results from previous studies
suggest that the ventral hypothalamic signal may derive from
astrocytes rather than neurons [40–42]. We routinely executed
imaging controls in order to distinguish immunofluorescent signal
from non-specific autofluorescence (e.g. accumulations of lipofus-
cin in cellular somata). Figure 2D presents an example from the
external globus pallidus (see Methods for details).
In Figure 3A we present ErbB4 expression in a section through
the hippocampal formation, posterior thalamus, and mesenceph-
alon. The overview image shows that the overall level of ErbB4
immunofluorescence was clearly lower in the hippocampal
formation compared to dorsal neocortical areas. However, higher
magnification reveals that expression was high in multipolar cells
scattered throughout the hippocampus. It is also evident that many
cells in the subgranular zone located at the border between the
granule cell layer and the hilus were ErbB4-positive (Figure 3B).
With exception of the RTN, ErbB4 protein expression was low in
the thalamus, intermediate in the central gray nucleus, and again
low in the substantia nigra pars compacta (Figure 3C). Figure 3D
presents another example for detection of autofluorescence from
the lateral geniculate nucleus.
ErbB4 expression is high in areas of the ‘‘corticolimbic
system’’
Next, we investigated ErbB4 expression in more detail by using
confocal microscopy to increase magnification and resolution, and
by using different neuronal markers in double-immunofluores-
cence to identify neuronal subtypes. We present our findings
arranged in functional systems, and we start with areas of the
‘‘corticolimbic system’’ [43–45] that are important for the proper
execution of different types of memory (prefrontal cortex,
hippocampus), attention and goal-directed behavior (prefrontal
and anterior cingulate cortex), and emotion and reward
(amygdala, nucleus accumbens). These different areas have also
been implicated in the etiology of schizophrenia [46–48].
We began by analyzing the prefrontal cortex using double-
immunofluorescence for ErbB4 and a principal neuron marker
(Figure 4). ErbB4 was detected with a rabbit monoclonal antibody
(mAb-10) directed against an intracellular epitope [11] and principal
neurons were labeled with an antibody raised against neurofilament
H [32]. We found high expression levels of ErbB4 in somata and
dendrites of many multipolar neurons scattered throughout layers 2–
6 and a few immunoreactive interstitial neurons in white matter. This
pattern was largely identical in medial and dorsolateral prefrontal
cortex (Figure 4A, C), anterior cingulate cortex (Figure 4E), and
insular cortex (Figure 4H).We verified with an additional marker that
ErbB4 immunoreactivity was consistently absent from pyramidal
neurons (Figure 4F). Figure 4G shows absence of immunofluores-
cence in control experiments.
Next, we analyzed ErbB4 expression in the hippocampal
formation using combinations of mouse mAb-77 with rabbit
antibodies against either GAD67, in order to identify GABAergic
interneurons, or neurogranin, which labels glutamatergic principal
cells. A profile through the major subregions of the hippocampus
(Figure 5A) shows that ErbB4 is expressed in many GAD67-
positive neurons in the CA1 (Figure 5B), dentate gyrus (Figure 5C),
and CA3 (Figure 5D). ErbB4 is also expressed in many neurons in
the deep stratum oriens close to the alveus and in the subgranular
zone of the dentate gyrus (Figure 5E). In addition, ErbB4-positive
cells are detected at lower density throughout all hippocampal
layers (Figure 5F–H). Please note the lack of ErbB4 and
neurogranin coexpression (Figure 5E–H), indicating that receptor
expression is restricted to interneurons, consistent with our
findings in the mouse hippocampus [10].
ErbB4 expression in areas of sensory and motor systems
We next investigated ErbB4 immunoreactivity in primary
sensory cortical areas (visual V1, somatosensory S1) and major
areas of the motor system (primary motor cortex F1, supplemental
motor cortex F3, basal ganglia) using mAb-10 and neurofilament
H antibodies in double-immunofluorescence experiments. Our
results show generally lower levels of ErbB4 expression in both
motor (Figure 6A, E) and sensory (Figure 6G, I) cortices, as
compared to frontal cortical areas (cf. Figure 4). Expression was
usually medium to high in apical layers but much weaker in basal
layers, with the notable exception of area V1 that showed two
broad bands of high expression in apical and in basal layers, and
only sparse expression in between (Figure 6G). Nuclei of the basal
ganglia, related to motor function, displayed different levels of
ErbB4 immunoreactivity. The strongest immunofluorescence was
detected in putamen (Figure 6C), followed by the caudate nucleus
(Figure 6B), and less signal in the pallidum (Figure 6D). Higher
magnification shows that all three nuclei display sparsely
distributed multipolar cells with relatively weak ErbB4 expression
compared to cortical interneurons. Most of the immunofluores-
cence in caudate and putamen represents diffuse signal consistent
with expression on neuropil that might potentially originate from
dopaminergic axons. Of note, the signal intensity in the basal
ganglia appears to be much lower compared to the overview
images presented in Figures 1 and 2. This difference is mainly due
to the fact that the low-resolution overview images in Figures 1, 2,
3 integrate signal from somata and background. In addition, these
images were taken with a 10x objective using epifluorescence,
resulting in signal collection practically across the entire depth of
the section. In contrast, the full resolution images in Fig. 6B–D
Figure 3. Overview on ErbB4 expression in caudal thalamus, hippocampus, surrounding cortex, mesencephalon, and
metencephalon. (A) Single epifluorescence images (1102) were taken at 10x magnification and automatically assembled; antibodies and channels
as in Figure 1. The drawing indicates the approximate anteroposterior position of the section (red line). ErbB4 expression is evident in all cortical
areas; however, immunoreactivity is stronger in dorsal compared to ventral areas. Several brainstem nuclei (CGr, IP, lateral PGr) show medium to high
intensity immunofluorescence. Original resolution is shown in hippocampal dentate gyrus (B) where ErbB4 expression is restricted to small multipolar
neurons (arrows), and in the substantia nigra (C) where immunofluorescence in the green channel is generally weak compared to the cortex.
Immunofluorescence of TH highlights Cd and somata in the dopaminergic brainstem nuclei (arrows in C). (D) Please note that red signal in the LGN
(location is indicated by the yellow box in A) derives mostly from autofluorescence (indicated by arrowheads in 546 nm and 633 nm images) rather
than from specific immunoreactivity; arrows identify a TH-positive axon in the 546 nm image. Scale bar=2 mm (A), 220 mm (B–D). Abbreviations:
Third ventricle (3
rdv), posterior cingulate cortex (23), cornu ammonis 1/3 (CA1/3), caudate (Cd), central gray (CGr), cerebral peduncle (cp), dentate
gyrus (DG), entorhinal cortex (EC), granule cell layer (gcl), hilus (hi), interpeduncular nucleus (IP), lateral geniculate nucleus (LGN), lateral ventricle (lv),
molecular layer (ml), pontine gray (PGr), pulvinar (Pv), reticular thalamic nucleus (RTN), subiculum (Sub), substantia nigra (SN).
doi:10.1371/journal.pone.0027337.g003
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(collecting signal from a much thinner z-plane) to allow the
separation of individual somata from the surrounding background.
ErbB4 is expressed in different subpopulations of cortical
interneurons
Here, we have shown ErbB4 expression in hippocampal
interneurons (Figure 5) and absence of ErbB4 immunofluores-
cence from pyramidal cells in many cortical areas, including
examples of sensory, motor, and association cortices (Figs 4, 6).
Moreover, we have recently identified several different subtypes of
ErbB4-positive interneurons in the frontal cortex of monkeys [12].
In order to verify this expression pattern in an additional area of
the primate cortex we went on to analyze cellular ErbB4
expression in the insula (Figure 7A–D). Using double-immunoflu-
orescence we detected ErbB4 protein in all four different subtypes
of GABAergic interneurons investigated, namely those expressing
neuronal nitric oxide synthase, calretinin, parvalbumin, and
somatostatin. The distribution of ErbB4 in the insula is thus
Figure 4. ErbB4 expression in limbic association cortices. The number of ErbB4 expressing cells (mAb-10, green channel) is similarly high in
limbic cortices such as areas 32 (A), 46 (C), 24 (E) and insular cortex (H). ErbB4-immunoreactivity is restricted to neuropil in layer I, whereas the number
of ErbB4-positive neuronal somata is high in layers II–IV, intermediate in layer V, and low in layer VI. The red channel shows neurofilament H
immunofluorescence in panels (A, C, E, H) or neurogranin in (F). Note that immunoreactivity for ErbB4 (arrows) is mostly absent from neurofilament H-
positive cells (open arrows), consistent with ErbB4 expression in interneurons. Exceptions are shown in (C’’, E’), where dendrites of large ErbB4
positive cells are labeled by neurofilament H. However, the shape of these cells is multipolar and not pyramidal-like and no overlay is detectable
using neurogranin as marker for pyramidal cells in area 24 (F). Please note that ErbB4 in (F) was visualized with mouse mAb-77 instead of mAb-10 (A,
C, E, H) and a different experimental protocol was used, thus resulting in somewhat weaker immunofluorescence and thinner dendrites.
Immunofluorescent signal was entirely absent when primary antibodies were omitted (G); the example is from area 24. The location of the
microscope images within the monkey brain is indicated by yellow rectangles in (B, D, I). Images were obtained with a confocal microscope. Scale
bar=400 mm (A, C, E–H), 175 mm (A’, C’, E’, H’), 125 mm (C’’).
doi:10.1371/journal.pone.0027337.g004
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(mAb-77, green channel) coexpress GAD67 (red channel; arrowheads in B–D). Moreover, the multipolar shape of neurons implicates interneurons
rather than pyramidal cells, even if some ErbB4-positive cells do not express GAD67 (open arrows). Note that not all GAD67-positive neurons express
ErbB4 in the soma (arrows in B–C). The overview of the hippocampal formation (E) using a rabbit neurogranin antiserum (rbNG) to identify principal
neurons, shows low concentration of ErbB4 in principal cell layers of cornu ammonis and DG, but high expression in molecular layers and a high
number of ErbB4-positive somata in the basal stratum oriens of CA1 and throughout the Sub. (F–H) Consistently, we find a lack of coexpression of
ErbB4 (open arrows in F’–H’) and the principal cell marker neurogranin (arrows F’–H’) in CA1-3 and in DG. Images were obtained with a confocal
microscope. Scale bar=200 mm (A), 50 mm (B–D), 470 mm (E), 100 mm (F–H), 32 mm (F’–H’). Abbreviations: Cornu ammonis 1/3 (CA1/3), dentate gyrus
(DG), fimbria (fi), granule cell layer (gcl), hilus (hi), molecular layer (ml), stratum lacunosum molecular (slm), stratum oriens (so), stratum pyramidale
(sp), stratum radiatum (sr), subiculum (Sub).
doi:10.1371/journal.pone.0027337.g005
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with expression in hippocampal interneurons, suggesting that this
pattern might be representative for the cerebral cortex of monkeys.
In addition, we detected ErbB4-immunoreactivity in a small
population of spiny interneurons in the stratum oriens of
hippocampal CA3 (Figure 7E, F). The multipolar shape, the
tangential orientation, and the location in the stratum oriens of
CA3 are indicative of interneurons and are consistent with a
previous description in rodents [49]. We found these cells on
several sections from either of the two monkeys; however, their
number was always low and we did not verify whether they might
be GABAergic, cholinergic, or glutamatergic. Of note, these cells
in stratum oriens should not be confused with the well known
glutamatergic spiny interneurons in stratum lucidum of CA3 [50]
or with the population of GABAergic spiny interneurons that have
been described in the hippocampal hilus [51]. In any case, the
identity and function of these neurons in stratum oriens and the
role of ErbB4 in their spines are unclear and warrant further
investigation.
ErbB4 expression in subcortical limbic structures:
Amygdala and nucleus accumbens
Next, we investigated subcortical areas of the limbic system that
were previously shown to express high levels of ErbB4 mRNA in
rodents [7,36–38]. As shown in Figure 8, ErbB4 immunoreactivity
occurs in multipolar neurons in the nucleus accumbens and
ventral pallidum (Figure 8A2, A3); while most of these neurons are
GABAergic (Figure 8B), we found that a subset is cholinergic
(Figure 8C). In addition, we detected very high ErbB4 immuno-
reactivity in patches throughout the nucleus accumbens and
additional structures of the rostral ventral forebrain, both in
monkeys (Figure 8A, D) and in mice (Figure 8H). The location
suggests that some of these patches could represent islands of
Calleja, areas of the ventral pallidum and the rostral migratory
stream, that are known to express high levels of ErbB4 in rodents
[22,52]. The general pattern of high ErbB4 immunoreactivity in
patches is very similar for mRNA, as evident from an image
showing in situ hybridization in mouse nucleus accumbens
(Figure 8G) obtained from the Allen Brain Atlas [25]. These
observations warrant further investigation in order to unequivo-
cally classify ErbB4-expressing cells in these structures and to
analyze the subcellular targeting of the receptor within somata and
neuropil.
With respect to the amygdala, we found patches of high ErbB4
immunoreactivity in the monkey (Figure 9A), and detection of
mRNA (obtained from the Allen Brain Atlas) reveals a similar
pattern (Figure 9B). We suggest that these patches correspond to
the inhibitory intercalated nuclei of the amygdala. High
magnification revealed structures indicative of ErbB4 expression
in large glomeruli-like structures or small somata that are
surrounded by intense and diffuse immunofluorescence
(Figure 9E1’, E1’’). This result is consistent with previous reports
in rodents [7,35,37], and is again supported by immunofluorescent
labeling (Figure 9I) and the Allen Brain Atlas (Figure 9J). Besides
the intercalated nuclei, the cellular expression pattern of ErbB4
was similar to other cortical areas in the periamygdaloid cortex 3
(Figure 9D). In subcortical nuclei of the amygdala, however,
immunoreactive cells were sparsely distributed and overall
expression levels were lower (Figure 9E–G). Occasionally, we
found co-immunofluorescence of ErbB4 and neurofilament H
(Figure 9G’), raising the possibility that a small subset of cells other
than inhibitory interneurons might express ErbB4 in subcortical
nuclei of the amygdala.
ErbB4 expression in diencephalic and mesencephalic
nuclei
We next investigated ErbB4 protein expression in the
diencephalon and mesencephalon since high levels of mRNA
have repeatedly been reported in the rodent reticular thalamic
nucleus, habenula, ventral hypothalamus, and in the dopaminer-
gic substantia nigra and ventral tegmental area [7,9,35,38,53,54].
Consistent with these studies, we detected medium levels of ErbB4
protein on both neurites and neuronal somata throughout the
reticular thalamic nucleus (Figure 10A); virtually all somata were
immunoreactive for parvalbumin (Figure 10B). Very high
immunoreactivity occurred in small spots in the habenula
(Figure 10E); however, we could not identify any cellular structures
even at 100x magnification using confocal microscopy. We also
investigated the mediodorsal thalamic nucleus (Figure 10C)
because it projects specifically to the prefrontal cortex and is thus
considered part of the ‘‘limbocortical’’ network of areas that
generally showed high levels of ErbB4 expression (cf. Figures 4, 5,
8, 9), but found ErbB4-immunoreactivity to be largely absent.
High ErbB4 expression occurred in the arcuate hypothalamic
nucleus (Figure 10F); high magnification revealed ErbB4 expres-
sion in large glomeruli-like structures or small somata in this area
that are surrounded by intense and diffuse immunofluorescence.
Expression of ErbB4 has been reported in hypothalamic astrocytes
that are involved in the neuroendocrine regulation of sexual
maturation and reproductive capacity of rodents [40,41], and in
vitro analysis of human fetal astrocytes has indicated that
hypothalamic but not cortical astrocytes express ErbB4 [42].
Thus, these studies suggest that our finding of high immunoreac-
tivity in the hypothalamus of rhesus monkeys likely results from
expression in astrocytes rather than neurons. Taken together,
contrary to the expression pattern in the cortex, the patches of very
high immunoreactivity in the rostral ventral forebrain, the
intercalated nuclei of the amygdala, selected thalamic nuclei,
and the ventral hypothalamus displayed diffuse labeling, and few
clearly defined structures could be identified even at high
Figure 6. ErbB4 expression in sensory-motor areas. In both the supplementary (A) and the primary motor cortex (E), ErbB4-positive cells are
concentrated in layer II. ErbB4-immunoreactivity (mAb-10, green channel) is restricted to small multipolar cells (arrows) but is absent from the large
Betz cells that are neurofilament H-positive layer V pyramidal neurons (red channel, open arrows in A, A’, E, E’). ErbB4 expression in the basal ganglia
is generally more diffuse and mostly lower compared to the cortex. Within the different nuclei, expression is intermediate in the caudate (B), highest
in the putamen (C), and lowest in pallidum (D). Higher magnification shows that the expression on individual cells is low (B’–D’). In the primary visual
cortex (G, G’), ErbB4 expression is higher compared to other sensory cortical areas and high numbers of immunoreactive somata are evident in layers
II and upper layer III, as well as in layer IV-Ca. Intensely-labeled larger somata are spread throughout layer V and, at lower density, layer VI. In the
somatosensory cortex (I), ErbB4 is mostly expressed in apical layers I–III. In either sensory cortex (G’, I’, I’’), higher magnification shows that ErbB4
expression is restricted to multipolar cells (arrows) but is absent from pyramidal cell somata and thick dendrites (open arrows). Some ErbB4
expression occurs on small diameter neurofilament H-positive neurites (arrowheads). The location of the microscope images within the monkey brain
is indicated by yellow rectangles in (F, H, J). The red channel shows neurofilament H expression in all panels. Images were obtained with a confocal
microscope and imaging parameters were held constant between panels A–E, G, I to allow the comparison of signal intensities between different
areas. Scale bar=400 mm (A–E, G, I), 175 mm (A’–E’, G’, I’), 125 mm (I’’).
doi:10.1371/journal.pone.0027337.g006
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additional markers and the use of electron microscopy are needed
to identify the exact source of ErbB4 immunoreactivity in these
areas.
An overview on the mesencephalon shows that ErbB4-
immunoreactivity was clearly above background level in the red
nucleus (i.e., nucleus ruber), substantia nigra pars compacta (SNc),
and ventral tegmental area (VTA) (Figure 11B); however, please
note that the absolute level of immunofluorescence is much lower
than in the cortex because the confocal detector sensitivity during
microscopic image acquisition was strongly increased compared to
Figure 3. The overall ErbB4 signal intensity was highest in the
SNc, where the highest density of ErbB4 mRNA expressing cells
were observed by in situ hybridization [7,35,37,38]. Higher
magnification reveals that most of the signal derived from
structures reminiscent of neuropil in all three nuclei (Figure 11C–
E). However, low-level ErbB4 immunoreactivity was evident on a
subset of TH-positive dopaminergic neuronal somata in the VTA
and SNc (Figure 11F–G).
Discussion
Our study represents the first extensive analysis of ErbB4
protein expression throughout major areas of the primate
cerebrum. In order to emphasize the potential functional role of
ErbB4 receptors, the results on their expression patterns were
organized according to anatomical considerations in areas
associated with corticolimbic, sensory and motor functions in the
cortex, and associated with the subcortical telencephalon,
diencephalon and mesencephalon. For this study we used two
highly specific and well characterized monoclonal antibodies,
targeting either an extracellular or an intracellular epitope of
ErbB4, that produce essentially identical patterns of immunore-
activity [10–12]. We found a strong correlation between protein
Figure 7. ErbB4 is expressed in different populations of cortical interneurons. Using double-immunofluorescence we detected ErbB4
expression (mAb-10 or mAb-77, green channel) in different subsets of interneurons (red channel) in the insular cortex. (A) Interneurons with low
nNOS-immunoreactivity showed coexpression of ErbB4 (arrowheads), whereas high-expressing cells were consistently ErbB4 negative (arrows). (B)
Many CR-positive interneurons in layers 2–3 were immunoreactive for ErbB4 (arrowheads). (C) Almost all PV neurons coexpressed ErbB4 throughout
all cortical layers. (D) The number of SOM-positive interneurons was low in the insular cortex, and a subset coexpressed ErbB4. (E) Occasionally, we
detected ErbB4 in a population of hippocampal spiny interneurons in lower stratum oriens of the CA3 region. (F, F1-29) Higher magnification shows
ErbB4 immunofluorescence within the somatodendritic compartment including the spines. Scale bar=200 mm (A–D), 120 mm (E), 60 mm (F), 35 mm
(F1-29). Abbreviations: alveus (alv), calretinin (CR), neuronal nitric oxide synthase (nNOS), parvalbumin (PV), somatostatin (SOM), stratum oriens (so).
doi:10.1371/journal.pone.0027337.g007
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areas, despite the fact that most published data on ErbB4 mRNA
were derived from rodents. This finding prompted us to include
parallel experiments in monkey and mouse nucleus accumbens
and amygdala that yielded very similar patterns of protein
expression in both species. These results are consistent with our
prior findings in the frontal cortex of mice, rats, monkeys and
humans that also showed regional and cellular conservation of
ErbB4 expression across species [12], suggesting an evolutionarily
conserved pattern of ErbB4 expression in the brain. However, we
cannot exclude the possibility that future studies, using other
markers or methods (i.e., electron microscopy), may reveal species-
dependent differences in cellular expression and subcellular
targeting of ErbB4, since this initial assessment is based on
experiments using a limited number of monkeys, markers and
mostly low-resolution approaches.
Comparison of ErbB4 expression in rodents and primates
Several studies have investigated ErbB4 mRNA expression in
rodents by in situ hybridization and, besides dot-patterned
expression throughout the entire cerebral cortex, consistently
reported on high subcortical expression levels in the ventral
forebrain, amygdala, habenula and reticular thalamic nucleus,
ventral hypothalamus, and ventral mesencephalon [7,35,37,38].
Figure 8. Consistent pattern of high-level ErbB4 expression in the ventral striatum of monkeys and mice. Overviews on the ventral
striatum and basal forebrain in the monkey (D) and the mouse (H) show similar patterns of patches of high ErbB4 (mAb-10, green channel)
immunoreactivity (arrows). Higher magnification (A, A1, A1’, H’) reveals that in these patches ErbB4 is located on neuropil and glomeruli-like
structures or, possibly, on small somata (arrowheads in A1’). In contrast, larger ErbB4-expressing somata reside in the NAC and VP outside of the
patches (arrows in A2, A3). Double-immunofluorescence labeling in the NAC shows that most ErbB4-positive somata coexpress GAD67 (B), whereas a
subset coexpresses ChAT (C); arrowheads label coexpressing neurons. In the mouse, the pattern of ErbB4 protein expression (H) is largely consistent
with mRNA expression (G) as obtained from the Allen Brain Atlas (Seattle, WA: Allen Institute for Brain Science.  2004–2011. Available from: http://
www.brain-map.org). The red channel shows immunofluorescence for neurofilament H (SMI-32) in (A, A1–A3, A1’, D), GAD67 (B), or ChAT (C) in the
monkey, and parvalbumin expression in the mouse (H, H’). Note ErbB4-parvalbumin coexpressing cells in VP (H’, arrowheads). The locations of the
overview images within the monkey (D) and mouse (H) brain are indicated by red rectangles in the respective drawings (E, F). The location of the
higher magnification profile (A) is indicated by the yellow box in (E). Images were obtained with a confocal microscope except for (B, C) that were
taken by epifluorescence microscopy. Scale bar=2.4 mm (D), 1.2 mm (H), 540 mm (A), 300 mm (H’), 150 mm (A1–A3, B, C), 60 mm (A1’). Abbreviations:
anterior commissure (ac), choline acetyltransferase (ChAT), caudate-putamen (CPu), major island of Calleja (ICm), nucleus accumbens (NAC), olfactory
tubercle (OTu), piriform cortex (PirC), ventral pallidum (VP).
doi:10.1371/journal.pone.0027337.g008
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PLoS ONE | www.plosone.org 14 November 2011 | Volume 6 | Issue 11 | e27337Figure 9. ErbB4 protein expression in the amygdala of monkeys and mice. Overview images show that both ErbB4 protein (A) and mRNA
(B) are highly expressed in patches in the amygdala that correspond to the intercalated nuclei. Higher magnification reveals a higher number of
ErbB4-positive neurons (mAb-10, green channel) in the cortical amygdala PAC3 (D) compared to the subcortical nuclei (E–G); examples of neurons are
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[25], and we have included examples from the amygdala and
nucleus accumbens in the results. The expression of ErbB4 in
rodent TH-positive mesencephalic neurons was shown by in situ
hybridization. Moreover, simultaneous decreases of both mRNAs
during adulthood and aging [55] or following 6-hydroxydopa-
mine-induced dopaminergic lesion [35] were reported in rats,
further arguing for ErbB4 expression in dopaminergic neurons.
With respect to ErbB4 protein, several studies have provided
detailed analyses of cellular and subcellular expression in rodent
interneurons of the neocortex, hippocampus and olfactory bulb
[8,10,11,15,22–24], but little is known about expression in
subcortical structures except for the ventral mesencephalon (see
above) and the ventral hypothalamus [40,41].
In primates, including humans, much less data are presently
available. Several studies investigated ErbB4 protein expression in
indicated by arrows in (D’–G’). Further magnification shows a pattern of dense ErbB4 immunoreactivity surrounding immunonegative cell somata in
the intercalated nuclei (somata labeled with asterisks in E1’’) and labeling of glomeruli-like structures or, possibly, small somata (arrowheads in E1’’).
The red channel shows neurofilament H-immunofluorescence in the monkey (A, D–G) and parvalbumin expression in the mouse (I). Please note
ErbB4-parvalbumin coexpressing cells in BLA (arrowheads in I’). The location of the overview images within the monkey (A, B) and mouse (I, J) brain is
indicated by red rectangles in the drawings (C, H); the position of the profiles through the monkey amygdaloid nuclei (D–G) is indicated by yellow
boxes in (C). Images were obtained with a confocal microscope. Images on expression of ErbB4 mRNA in the monkey (B) and the mouse (J) amygdala
were obtained from the Allen Brain Atlas (Seattle, WA: Allen Institute for Brain Science.  2004–2011. Available from: http://www.brain-map.org).
Scale bar=2.4 mm (A, B), 1.2 mm (I), 400 mm (I’), 150 mm (D’–G’, E1’), 60 mm (E1’’). Abbreviations: accessory basal amygdala (aAB), basal amygdala
(BA), basolateral amygdala (BLA), basomedial amygdala (BMA), central amygdala (CeA), anterior cortical amygdala (COa), internal entorhinal cortex
(ECi), intermediate basal amygdala (iBA), intercalated amygdala (IcA), lateral amygdala (LA), optic tract (ot), periamygdaloid cortex 3 (PAC3), piriform
cortex (PirC), ventrolateral amygdala (vLA).
doi:10.1371/journal.pone.0027337.g009
Figure 10. ErbB4 protein expression in diencephalic nuclei. High ErbB4 (mAb-10, green channel) expression (arrows) occurs in the thalamic
RTN (A) and habenula (E). Higher magnification shows ErbB4 expression on glomeruli-like structures (arrows in A’, A’’) and on parvalbumin-positive
neuronal somata (arrowheads in B) in the RTN that are surrounded by neuropil (arrows in A, B). We detected patches of high ErbB4 expression but
could not identify cellular structures in the habenula even at high magnification (arrows in E’, E’’). In contrast, ErbB4 is almost absent from the MD
thalamus (C) except for immunoreactivity on a few neurites (arrows in C’) but not on somata (arrowhead in C’). We additionally found high expression
in neuropil of the arcuate hypothalamic nucleus of the monkey (F–F’’). The red channel shows neurofilament H-immunofluorescence in panels (A, C,
E, F) and parvalbumin in (B). The location of the microscope images within the monkey brain is indicated by yellow boxes in (D, G). Images were
obtained with a confocal microscope, except for (B) that was taken by epifluorescence microscopy. Scale bar=400 mm (A, C, E, F), 175 mm (A’, C’, E’,
F’), 150 mm (B), 70 mm (A’’, E’’, F’’).
doi:10.1371/journal.pone.0027337.g010
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PLoS ONE | www.plosone.org 16 November 2011 | Volume 6 | Issue 11 | e27337Figure 11. ErbB4 protein expression in mesencephalic nuclei. The overview on the mesencephalon (B) shows dense ErbB4 expression (mAb-
10, green channel) in the dopaminergic nuclei SNc and VTA that is clearly above background levels, whereas expression in the red nucleus is weaker.
Higher magnification shows abundant immunoreactivity on neuropil (C–E, C’–E’). At 100x magnification, a dense network of ErbB4-positive neuropil
surrounding a neuron (asterisk) is evident in the VTA (E’’). The red channel shows neurofilament H-immunofluorescence in panels (B–E) and TH-
immunofluorescence in (F–G). Co-immunolabeling reveals that subsets of TH-positive dopaminergic somata express ErbB4 in the VTA (F) and SNc (G);
coexpressing neurons are indicated by arrowheads (F–G), whereas lack of ErbB4 signal is indicated by arrows (G). The location of the overview image
within the monkey brain is indicated by a red rectangle in (A). The location of the profiles through mesencephalic nuclei is indicated by yellow boxes
in (A) and by rectangles in (B). Images were obtained with a confocal microscope. Scale bar=3 mm (B), 400 mm (C–E), 175 mm (C’–E’, F–G), 70 mm (E’’).
Abbreviations: cerebral peduncle (cp), oculomotor nerve (3n), substantia nigra pars reticulata (SNr).
doi:10.1371/journal.pone.0027337.g011
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reported widespread protein expression on both interneurons and
principal cells [26–28]. However, we have recently demonstrated
that the antibodies used in those studies exhibit major unspecific
cross-reactivity in monkey and human tissues [12]. Instead, we
showed that in the frontal cortex of monkeys and humans ErbB4 is
selectively expressed in interneurons and is absent from pyramidal
cells, consistent with findings in rodents [8,10,11]. Our current
study has extended these investigations by including many
functionally and cytoarchitecturally heterogeneous cortical regions
where the distribution, size and shape of ErbB4-immunoreactive
cells is consistent with expression in inhibitory interneurons.
Moreover, expression in GABAergic interneurons was directly
demonstrated in the hippocampus by double-immunofluorescence
with GAD67, and in the insular cortex with calcium binding
proteins and the neuropeptide CCK. Thus, our results suggest that
the pattern of interneuron-specific expression of ErbB4 is
maintained throughout the entire cerebral cortex in primates.
With respect to additional subcortical regions in the human
brain, ErbB4 mRNA is expressed in the ventral mesencephalon,
and indirect evidence suggests that the ventral hypothalamus
expresses high levels of ErbB4 [42]. Our current analysis generally
supports these findings which are also consistent with data
available from the Allen Brain Atlas [25]. This database provides
information obtained by in situ hybridization on ErbB4 expression
in several species, including rhesus monkeys and humans, but only
few regions of the monkey and human brain have been
investigated yet.
ErbB4 expression in different cell types
Generally, our results obtained from various regions of the
cerebral cortex are consistent with the selective expression of
ErbB4 in interneurons (see above). The primary visual cortex (V1)
showed high to medium levels of ErbB4 expression in two broad
bands roughly encompassing layers 2–3 and lower layer 4 to layer
6, respectively, and lower expression in between. This pattern is
reminiscent of the distribution of parvalbumin (PV)-positive
interneurons in V1 [56]. These findings, together with previous
reports on cell type-specific cortical expression in both primates
[12] and rodents [8], suggest that PV-positive cells probably
comprise the largest subpopulation of ErbB4-expressing interneu-
rons in the neocortex. We also detected ErbB4 protein expression
in the RTN. Unlike other thalamic nuclei, the RTN is composed
entirely of inhibitory projection and local-circuit neurons that
express PV [57]. Thus, our current results indicate that ErbB4
expression occurs in several populations of PV-positive cells, both
cerebral cortical interneurons and thalamic projection neurons.
ErbB4 receptor protein was also observed in the ventral
mesencephalon of the rhesus monkey. However, our finding that
ErbB4-immunoreactivity in dopaminergic nuclei is relatively lower
than in the cortex was unexpected, because high levels of ErbB4
mRNA have been repeatedly reported in the substantia nigra and
ventral tegmental area in both rodents and primates
[9,35,37,38,53,54]. Of note, we found that regions densely
innervated by dopaminergic fibers displayed diffuse ErbB4
immunoreactivity (i.e., caudate, putamen, nucleus accumbens
and additional regions of the ventral forebrain), raising the
possibility that much of the protein within dopaminergic neurons
may be transported to axons. This interpretation is supported by a
recent study that demonstrated accumulation of the radioactively
labeled NRG1-b1 extracellular domain in both the dorsal striatum
and substantia nigra following systemic application in C57Bl/6
mice [58].
In addition, we detected high ErbB4 protein expression in the
ventral hypothalamus of rhesus monkeys, which is consistent with
previous studies in mice and humans that reported ErbB4
expression in hypothalamic astrocytes [41,42]. Other investiga-
tions have implicated NRG1-ErbB4 signaling with the generation
of oligodendrocytes in the midbrain and brain stem of different
species [59], suggesting that ErbB4 expression may be less
restricted to neurons in brain regions other than the telenceph-
alon. Again, further studies are needed to characterize the exact
cellular sources of hypothalamic ErbB4 during development and
adulthood. In any case, the expression of the receptor protein in
different cell types suggests that the NRG-ErbB4 pathway may
well affect several functionally independent processes in the
mammalian brain.
Technical considerations
Our study was designed to provide a comprehensive qualitative
analysis on ErbB4 expression throughout many cortical and
subcortical areas of the monkey cerebrum. In order to provide this
first extensive overview in primates, we had to restrict ourselves to
qualitative approaches, relying mostly on assessment of the
intensity of overall immunofluorescent signal in specific brain
areas rather than on quantitative approaches such as cells counts.
There are a few limitations that merit consideration when
interpreting results using this type of qualitative approach. First,
protein expression and fluorescence intensity may not be linear if
there is steric interference of antibody binding and this limitation
may be further affected when using an enzyme-based signal
amplification procedure. Second, regional differences of tissue
quality will influence any histological analysis; possible factors
include variations in tissue thickness, uneven fixation as a function
of the distance to blood vessels, as well as artifacts resulting from
freezing, sectioning and tissue damage during the immunohisto-
logical processing. Third, inherent properties of the tissue can
affect antibody penetration (i.e., highly myelinated areas) and the
level of autofluorescence (i.e., lipofuscin-accumulation preferen-
tially in some subpopulations of cells).
With respect to the extent of coexpression, or lack thereof, of
two proteins in single cells, absence of co-immunolabeling is not
sufficient proof to categorically determine that both proteins are
either coexpressed or not in a cell population. This argument is
pertinent to the absence of ErbB4 expression on cortical pyramidal
cells that we identified with antibodies against neurogranin or
neurofilament H in the present study, and additionally CaMKIIa
in a recent publication [12]. However, because our immunohis-
tological results were obtained using two different antibodies for
ErbB4 and three independent markers of pyramidal cells, are
consistent with prior in situ hybridization and single-cell PCR
analyses in electrophysiologically identified cells in rodents [11,12],
we believe our conclusions regarding this point are well supported.
Functional considerations
Our results showthat the expression of ErbB4 protein is generally
much higher in areas of the ‘‘corticolimbic system’’ compared to
sensory-motor areas. We believe that this expression pattern is
plausible with the genetic association of NRG1 and ErbB4 with
schizophrenia, since the limbic association cortices are crucially
involved in many of the functions affected in the disorder, e.g.
selection of the focus of attention and suppression of irrelevant
stimuli, working memory, selection and change of strategies[60,61].
ErbB4 in the reticular thalamus is also of functional interest because
this nucleus has been implicated in maintaining the focus of
attention by selecting and enhancing relevant stimuli via afferents
originating in the dorsolateral PFC and efferent inhibitory
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in the amygdala and the nucleus accumbens implicate the NRG-
ErbB4 signaling pathway in neuronal processes that are related to
emotion, motivation, and reward [63–65]. Importantly, dense
dopaminergic innervation from mesencephalic nuclei, especially the
ventral tegmental area, is a common feature of limbic areas. The
ventral tegmental area is directly innervated by projections from the
prefrontal cortex (PFC) and is subject to modulation, or control, by
thePFC.This pathwaythusprovidesafeedbackloop thatallowsthe
PFC to influence signal processing in other limbic areas indirectly
via modulation of dopaminergic transmission [66,67]. It has been
shown that ErbB4 is not required for the development and
maintenance of dopaminergic neurons [68]. However, application
of NRG1 acutely augments dopamine release in the hippocampus
[20] and protects mesencephalic dopaminergic neurons against 6-
OHDA-induced neurotoxicity [69], suggesting that ErbB4 indeed
modulates the function of dopaminergic neurons in different ways.
We conclude from our investigation that the large-scale
organization of ErbB4 expression is largely conserved in rodents
and primates. The results of our first assessment of ErbB4 protein
expression throughout the cerebrum of primates thus validate the
use of mice with genetically altered ErbB4 expression for
investigations on the biological pathways and neuronal networks
involved in the etiology of schizophrenia. Of note, our findings
and data from other studies suggest that subcortical ErbB4
expression occurs in different populations of cells (dopaminergic
and GABAergic projection neurons, astrocytes) and may also be
targeted to axons; evidently, ErbB4 cellular and subcellular
expression is less restricted in subcortical structures than in the
cortex.
Supporting Information
Figure S1 Evaluation of area-specific ErbB4 immuno-
fluorescent signal intensity. Intensity of the green ErbB4
channel was evaluated in the entire area outlined by the purple
line (top). In addition, a histogram along the green line represents
pixel intensities within each area (bottom). Both the average pixel
intensity throughout the entire areas as well as the line histograms
indicate that immunofluorescent signal intensity is similarly high in
the caudate-putamen compared to cortical area 23/24.
(TIF)
Figure S2 Evaluation of relative differences of red and
green channel intensities in cortical areas. Images of
cortical areas were smoothed with a Gaussian filter (Passes:1;
Strength: 30 pixel) and the intensities of single color channels are
presented throughout cortical layers (histograms along the yellow
lines). Please note the differences between cortical areas with
respect to relative signal intensities in the red and green channel.
The red/green ratio is below 1 in area 46, about 1 in area V1, and
above 1 in area F1, indicating an increase of immunoreactivity of
the pyramidal cell marker neurofilament H (red channel) and a
reduction of ErbB4-immunoreactivity (green channel) from limbic
area 46 and sensory area V1 to motor cortex area F1, respectively.
(TIF)
Table S1 Morphological definition of cortical and
subcortical areas investigated. Table S1 provides operation-
al definitions for the location and boundaries of investigated brain
areas. Abbreviations are the same as introduced throughout the
text and in the figure legends.
(DOC)
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